Physician profile
Gregory G Bebb
NPI 1023098324
$2,647.42
in general payments reported to CMS, 2019-2025
44 companies · $711 in 2025
The $711 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $171 · 2021: $160 · 2022: $310 · 2023: $718 · 2024: $371 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,800.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molli Surgical (US) INC | $354.59 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $254.30 | 2020-2024 | Opdualag |
| Regeneron Healthcare Solutions, INC. | $179.51 | 2024-2025 | Libtayo |
| Merck Sharp & Dohme LLC | $175.12 | 2019-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Smith+Nephew, INC. | $120.61 | 2019-2025 | Grafix Pl, Stravix, Oasis |
| Elucent Medical | $115.03 | 2023-2025 | |
| Bard Peripheral Vascular, INC. | $114.03 | 2019-2024 | Encor |
| Tempus Ai, INC | $101.94 | 2024-2025 | Xt Cdx |
| Convatec INC. | $101.67 | 2024-2025 | |
| Imbed Biosciences INC. | $96.58 | 2023 | |
| Ethicon US, LLC | $74.45 | 2019-2022 | |
| Integra Lifesciences Corporation | $68.48 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tela Bio, INC. | $66.20 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Hologic Sales and Service, LLC | $64.38 | 2023-2025 | Coolseal Generator, Biozorb, Trunode |
| Kowa Pharmaceuticals America, INC. | $58.68 | 2023 | Seglentis |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $55.32 | 2021 | |
| Kci USA, INC. | $42.75 | 2019-2022 | |
| Heron Therapeutics, INC. | $41.08 | 2023-2025 | Zynrelef, Aponvie |
| Davol INC. | $38.96 | 2021-2023 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $38.12 | 2021 | |
| Myriad Genetic Laboratories, INC. | $36.43 | 2021-2023 | Myrisk |
| Innocoll Pharmaceuticals Limited | $34.58 | 2021-2022 | |
| Acell, INC. | $30.99 | 2019 | |
| Kerecis Limited | $29.86 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Vertex Pharmaceuticals Incorporated | $25.92 | 2025 | |
| Abbott Laboratories | $24.85 | 2019 | |
| Cashflow Solutions, LLC | $24.62 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Angiodynamics, INC. | $23.28 | 2025 | Smart Port Ct |
| Hologic INC | $22.16 | 2022 | |
| Daiichi Sankyo INC. | $21.24 | 2023 | Injectafer |
| Solventum Corporation | $20.32 | 2025 | Promogran Prisma |
| Intuitive Surgical, INC. | $19.96 | 2023 | |
| Organogenesis INC. | $17.86 | 2025 | Apligraf |
| Rti Surgical, INC | $16.81 | 2023 | |
| Aroa Biosurgery Incorporated | $16.40 | 2025 | |
| Tactile Systems Technology INC | $14.99 | 2024 | Entre Plus, Flexitouch Plus |
| Paratek Pharmaceuticals, INC. | $14.86 | 2023 | Nuzyra |
| Merit Medical Systems INC | $14.62 | 2023 | Savi Scout |
| Novo Nordisk INC | $14.31 | 2022 | |
| Cook Medical LLC | $14.03 | 2020 | |
| Medela LLC | $12.75 | 2022 | |
| Reprise Biomedical, INC. | $12.49 | 2025 | Miro3d |
| Janssen Pharmaceuticals, INC | $11.25 | 2019 | |
| Cardiovascular Systems INC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Bebb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.